The export of domestic plant extracts, vitamin series and other products is blocked due to us regulations

Recently, the reporter learned from China Chamber of Commerce for the import and export of medical and health products (hereinafter referred to as the chamber of Commerce for medical insurance) and China health care association that a new mandatory regulation on dietary supplements (i.e domestic health food) issued by the US FDA will have a greater impact on the export of domestic plant extracts, vitamins and other products Many related enterprises are paying close attention to this new regulation China Health Care Association and Shuzheng KANGXUN Business Consulting Co., Ltd have also jointly organized the training of dietary supplement raw material composition testing project for enterprises in combination with the National Natural Products Association (NPA) and the United States Pharmacopoeia Committee (USP) Experts from cGMP's chamber of Commerce for compulsory medical insurance told reporters that the US FDA announced on June 22 that cGMP transformation will be enforced for all companies that produce and sell vitamin / mineral preparations, plant preparations and various dietary supplements in the next three years; at the latest, cGMP transformation for health products enterprises will be completed within five years According to the new regulation, strict test reports must be provided for the raw materials of dietary supplements imported into the United States Wang Dahong, Secretary General of the health food market working committee of China Health Care Association, told reporters that since 70% - 80% of the dietary supplement raw materials in the United States are currently imported from China, the new regulation will have a greater impact on the Chinese health food raw materials export enterprises, "especially the plant extract export enterprises" In fact, the transition period of China's relevant raw material export enterprises is less than one year: according to the FDA, the mandatory provisions of cGMP certification will be implemented from June 2008 for large-scale health food production enterprises with more than 500 people in the country Due to the stricter trade environment for exports to the United States, the export of plant extracts, which performed strongly last year, has declined instead of increasing this year "In the first nine months of this year, the export amount of Chinese plant extracts was basically the same as that of the same period last year, but the export amount of plant extracts to the United States dropped by 35%, only 6.008 million US dollars." Yuan Jinghua, general manager of the medical insurance association, told reporters After the implementation of the new regulations, the export of domestic plant extracts will face a more serious situation As soon as possible, Wang Dahong told reporters that in the industrial chain of the health food industry in the United States, manufacturers purchase raw materials from local distributors, who import raw materials from Chinese suppliers, or the manufacturers directly entrust domestic enterprises to plant and produce them Chinese manufacturers only provide raw materials according to the standards of local enterprises in the United States, but these standards are not FDA standards Now FDA implements cGMP supervision on local enterprises and unifies production standards, which also sets a new trade threshold for Chinese suppliers According to FDA's testing requirements for health food raw materials, domestic raw material suppliers must improve production process and unify product standards to become qualified suppliers, which will undoubtedly increase the export cost of domestic enterprises An industry expert told reporters that the most needed investment of domestic manufacturers in this respect is the improvement of production process, such as oxidation value parameters Domestic manufacturers are currently "open production" The new FDA regulations have increased the requirements, which will urge domestic manufacturers to turn to "closed processing", and only this improvement will be a large expenditure What worries domestic manufacturers most is that the increase of export cost does not mean the increase of export price On the one hand, because most of the products are sold by American purchasers, the United States is in the leading position in price negotiation; on the other hand, the export environment also faces many uncertain factors, such as the change of RMB exchange rate "It's not a bad thing, it's going to lead to a standard concept." Wang added Previously, due to the uneven testing of raw materials for domestic export, some are self testing by qualified enterprises, some are going to the national or local CDC for testing The test standard is not uniform, and it is easy to be intercepted when entering the United States, which also affects the corporate brand In the face of changes in the international market, relevant experts suggest that domestic production enterprises should be prepared for changes as early as possible in the transitional period "The most important thing is that domestic enterprises should improve their technical level, turn resource advantage into market advantage, and transform from low added value to high added value in the industrial chain." Yuan Jinghua emphasized "NPA and USP are the authoritative certification bodies authorized by the FDA of the United States If Chinese health food raw material enterprises can pass the NPA or USP certification, it will help to export raw materials, which is also a major means for enterprises to cope with the new regulations." Wang Dahong suggested.